← BioTransfer GEO Dataset Finder
GEO series

Zalfermin and semaglutide have beneficial effects liver histology and fibrotic gene in a murine model of NASH

GSE256063 Mus musculus Expression profiling by high throughput sequencing 56 samples 2025/02/01 GPL19057
Summary
The potential clinical benefits of FGF21 analogues for the treatment of NASH has evolved significantly within the last years. However, despite clinical meaningful effect on NASH resolution and fibrosis the body weight loss in humans have been less impressive. Thus, a combination of an FGF21 analogue with a GLP-1 receptor agonist may add additional benefit to the treatment of NASH due to complimentary mode of action compared to stand alone therapies
Download
NCBI GEO page ↗ Paper (PMID 41150667) ↗ {# Names what the click gives you. "Open in finder" meant nothing to a visitor who arrived from a search engine and has never seen the tool. #} Find more mouse RNA-seq datasets →
Similar datasets

Search all mouse RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.